- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 11H: 9,10-dioxo-9,10-dihydroanthracene-2,6-disulfonic acid(Non-covalent)
11H.1: 8 residues within 4Å:- Chain A: R.163, I.171, N.173, K.311, P.312, H.371, F.373, Q.472
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:F.373
- Hydrogen bonds: A:N.173, A:Q.472
- Salt bridges: A:R.163
- pi-Stacking: A:F.373, A:F.373
11H.9: 8 residues within 4Å:- Chain B: R.163, I.171, N.173, K.311, P.312, H.371, F.373, Q.472
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:F.373
- Hydrogen bonds: B:N.173, B:Q.472
- Salt bridges: B:R.163
- pi-Stacking: B:F.373, B:F.373
11H.17: 8 residues within 4Å:- Chain C: R.163, I.171, N.173, K.311, P.312, H.371, F.373, Q.472
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:F.373
- Hydrogen bonds: C:N.173, C:Q.472
- Salt bridges: C:R.163
- pi-Stacking: C:F.373, C:F.373
11H.25: 8 residues within 4Å:- Chain D: R.163, I.171, N.173, K.311, P.312, H.371, F.373, Q.472
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:F.373
- Hydrogen bonds: D:N.173, D:Q.472
- Salt bridges: D:R.163
- pi-Stacking: D:F.373, D:F.373
- 4 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 9 residues within 4Å:- Chain A: Q.299, F.302, D.303, L.304, I.305, Q.341, H.342, G.343, I.344
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:I.305, A:G.343
GOL.10: 9 residues within 4Å:- Chain B: Q.299, F.302, D.303, L.304, I.305, Q.341, H.342, G.343, I.344
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:I.305, B:G.343
GOL.18: 9 residues within 4Å:- Chain C: Q.299, F.302, D.303, L.304, I.305, Q.341, H.342, G.343, I.344
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:I.305, C:H.342, C:G.343
GOL.26: 9 residues within 4Å:- Chain D: Q.299, F.302, D.303, L.304, I.305, Q.341, H.342, G.343, I.344
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:I.305, D:H.342, D:G.343
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 6 residues within 4Å:- Chain A: D.71, D.73, T.75, D.370, D.375
- Ligands: SO4.5
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.71, A:D.73, A:D.370, H2O.1, H2O.2
MG.11: 6 residues within 4Å:- Chain B: D.71, D.73, T.75, D.370, D.375
- Ligands: SO4.13
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.71, B:D.73, B:D.370, H2O.3, H2O.5
MG.19: 6 residues within 4Å:- Chain C: D.71, D.73, T.75, D.370, D.375
- Ligands: SO4.21
5 PLIP interactions:3 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:D.71, C:D.73, C:D.370, H2O.5, H2O.7
MG.27: 6 residues within 4Å:- Chain D: D.71, D.73, T.75, D.370, D.375
- Ligands: SO4.29
5 PLIP interactions:3 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.71, D:D.73, D:D.370, H2O.8, H2O.9
- 20 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 8 residues within 4Å:- Chain A: R.163, L.377, L.468, Q.472, R.475, Y.476
- Chain C: K.381, R.475
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain A: N.269, H.371
- Ligands: MG.3
Ligand excluded by PLIPSO4.6: 2 residues within 4Å:- Chain A: R.95, W.226
Ligand excluded by PLIPSO4.7: 4 residues within 4Å:- Chain A: G.149, P.150, R.153, K.159
Ligand excluded by PLIPSO4.8: 5 residues within 4Å:- Chain A: N.136, L.137, K.159, R.465
- Chain C: K.363
Ligand excluded by PLIPSO4.12: 8 residues within 4Å:- Chain B: R.163, L.377, L.468, Q.472, R.475, Y.476
- Chain D: K.381, R.475
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain B: N.269, H.371
- Ligands: MG.11
Ligand excluded by PLIPSO4.14: 2 residues within 4Å:- Chain B: R.95, W.226
Ligand excluded by PLIPSO4.15: 4 residues within 4Å:- Chain B: G.149, P.150, R.153, K.159
Ligand excluded by PLIPSO4.16: 5 residues within 4Å:- Chain B: N.136, L.137, K.159, R.465
- Chain D: K.363
Ligand excluded by PLIPSO4.20: 8 residues within 4Å:- Chain A: K.381, R.475
- Chain C: R.163, L.377, L.468, Q.472, R.475, Y.476
Ligand excluded by PLIPSO4.21: 3 residues within 4Å:- Chain C: N.269, H.371
- Ligands: MG.19
Ligand excluded by PLIPSO4.22: 2 residues within 4Å:- Chain C: R.95, W.226
Ligand excluded by PLIPSO4.23: 4 residues within 4Å:- Chain C: G.149, P.150, R.153, K.159
Ligand excluded by PLIPSO4.24: 5 residues within 4Å:- Chain A: K.363
- Chain C: N.136, L.137, K.159, R.465
Ligand excluded by PLIPSO4.28: 8 residues within 4Å:- Chain B: K.381, R.475
- Chain D: R.163, L.377, L.468, Q.472, R.475, Y.476
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain D: N.269, H.371
- Ligands: MG.27
Ligand excluded by PLIPSO4.30: 2 residues within 4Å:- Chain D: R.95, W.226
Ligand excluded by PLIPSO4.31: 4 residues within 4Å:- Chain D: G.149, P.150, R.153, K.159
Ligand excluded by PLIPSO4.32: 5 residues within 4Å:- Chain B: K.363
- Chain D: N.136, L.137, K.159, R.465
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jordheim, L.P. et al., Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening. Biochem Pharmacol (2013)
- Release Date
- 2012-12-26
- Peptides
- Cytosolic purine 5'-nucleotidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 11H: 9,10-dioxo-9,10-dihydroanthracene-2,6-disulfonic acid(Non-covalent)
- 4 x GOL: GLYCEROL(Non-functional Binders)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 20 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jordheim, L.P. et al., Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening. Biochem Pharmacol (2013)
- Release Date
- 2012-12-26
- Peptides
- Cytosolic purine 5'-nucleotidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A